The QualityStocks Daily Wednesday, June 4th, 2025

Today's Top 3 Investment Newsletters

Green Car Stocks(MULN) $16.1000 +198.70%

360 Wall Street(STSS) $6.3100 +68.72%

QualityStocks(HOTH) $1.5300 +66.34%

The QualityStocks Daily Stock List

Hoth Therapeutics (HOTH)

QualityStocks, StreetInsider, StockMarketWatch, RedChip, MarketClub Analysis, PennyStockProphet, Broad Street, OTCtipReporter, Penny Pick Finders, PennyStockLocks, StockRockandRoll, Penny Stock 101, OTCBB Journal, BUYINS.NET, HotOTC, StockOnion, Premium Stock Alerts, MarketBeat, Schaeffer's, Profitable Trader Authority, INO Market Report, Buzz Stocks, PennyStockScholar, 360 Wall Street, StockHideout, 247 Market News, Jeff Bishop, TradersPro and Planet Penny Stocks reported earlier on Hoth Therapeutics (HOTH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hoth Therapeutics Inc. (NASDAQ: HOTH) is a biopharmaceutical firm that is focused on the de-velopment of therapies for atopic dermatitis and other ailments such as psoriasis, acne, asthma and chronic wounds.

The firm, which serves consumers in the United States and is based in New York, was founded in May 2017 by James Ahern, Matthew D. Eitner and Robbie Knie.

Hoth Therapeutics is engaged in the development of eczema therapies, having developed its thera-peutic platform called BioLexa Platform, which is a patented and drug compound platform for the treatment of eczema. This product is designed to prevent any flare-ups that can trigger eczema symptoms even before they occur. The firm also explores the use of its platform in the aesthetic dermatology field to help reduce and treat post-procedure infections, improve clinical outcomes for individuals undergoing procedures and speed up the healing process.

Hoth Therapeutics (HOTH), closed Wednesday's trading session at $1.53, up 66.3405%, on 31,515,296 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $0.58/$3.8.

Cellectar Biosciences (CLRB)

StockMarketWatch, PCG Advisory, MarketClub Analysis, QualityStocks, InvestorPlace, TraderPower, MarketBeat, Wall Street Resources, Jason Bond, Premium Stock Alerts, SeeThruEquity Research, StreetInsider, BUYINS.NET, OTC Markets Group, Marketbeat.com, TradersPro, Wall Street Mover, Schaeffer's, Wealth Insider Alert, Stock Beast, Stock Market Watch, Stock News Now and Investing Futures reported earlier on Cellectar Biosciences (CLRB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cellectar Biosciences Inc. (NASDAQ: CLRB) (FRA: NV4P) is a clinical biopharmaceutical firm that is engaged in discovering, developing and commercializing therapies for treating cancer.

The firm has its headquarters in Florham Park, New Jersey and was incorporated in June 1996. It operates in the health care sector, under the biotech and pharma sub-industry. The firm is party to collaborative PDC programs with Orano Med and Avicenna Oncology GMBH, which entails the development of the CLR 12120 Series and the CLR 2000 Series.

The company is focused on developing targeted phospholipid drug conjugates for imaging and treating cancer. Its pipeline is made of clinical and pre-clinical product candidates, which include chemotherapeutic and radio-therapeutic phospholipid drug conjugates.

The enterprise’s product candidates include a phospholipid drug conjugate (PDC) chemotherapeu-tic program dubbed CLR1900, which is in its pre-clinical stage for the treatment of solid tumors; a PDC dubbed CLR 131, which is currently in its phase 1 study for treating refractory and relapse multiple myeloma, neck and head cancers and pediatric cancers; a phase 2b study for patients with refractory and relapsed multiple myeloma and phase 2 clinical trial for patients with refractory or relapsed B-cell malignancies and Waldenstrom's macroglobulinemia. The enterprise provides its products to the healthcare, pharmaceutical and medical industries. In addition to this, the enterprise also develops CLR 1502. CLR 124, CLR 125, CTX CLR 1700, CTX CLR 1602-PTX and CTX CLR 1800-P.

Cellectar Biosciences (CLRB), closed Wednesday's trading session at $0.4617, up 66.3184%, on 626,106,016 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.224/$3.42.

Baosheng Media Group Holdings (BAOS)

QualityStocks, MarketClub Analysis, Trades Of The Day, TradersPro, The Online Investor, Premium Stock Alerts, MarketBeat and INO Market Report reported earlier on Baosheng Media Group Holdings (BAOS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Baosheng Media Group Holdings Limited (NASDAQ: BAOS) is a holding firm that operates as an online marketing solution provider.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in 2014 by Wenxiu Zhong. It operates as part of the media industry, in the communications sector, under the advertising and marketing sub-industry and serves consumers in China.

The company provides 2 types of advertising services: Non-search engine marketing services and Search engine marketing services. Non-search engine services include in-feed advertising, social media marketing and mobile app advertising by deploying ads on mobile apps, news portals, short-video platforms and social media platforms. On the other hand, search engine marketing services involve deploying ranked search ads and other display search ads provided by search engine op-erators.

The enterprise connects online media and advertisers and helps them manage their online market-ing activities in different ways, which include administrating and fine-tuning the ad placement pro-cess, providing ad optimization services, and advising on advertising strategies and choices as well as budgets of advertising channels. It also serves media businesses by engaging in promotion and marketing activities aimed at inducing and educating advertisers to use online advertisements, facil-itating payment arrangements with advertisers and identifying advertisers to purchase their ad in-ventory.

Baosheng Media Group Holdings (BAOS), closed Wednesday's trading session at $3.66, up 54.4304%, on 36,194,951 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $1.44/$13.66.

ViewBix Inc. (VBIX)

QualityStocks, Small Cap Firm, StockHideout, StockWireNews, StockOnion, Profitable Trader Authority, PennyStockScholar, PennyStockProphet, Penny Pick Finders, OTCtipReporter, Leading Penny Stocks, HotOTC, Fierce Analyst and DividendStocks reported earlier on ViewBix Inc. (VBIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ViewBix Inc. (OTCQB: VBIX) is a video analytics and technology firm that allows consumers to add calls to action and applications that drive engagement and share that experience across various networks.

The firm has its headquarters in Herzliya, Israel and was incorporated in 1989 by Lior Wayn. Pri-or to its name change, the firm was known as Virtual Crypto Technologies Inc. It operates as part of the computer systems design and related services industry. The firm has four companies in its corporate family and serves consumers around the globe.

The company is based on a freemium model. It provides a base product without charges but plans to begin charging a monthly fee for detailed analytics, premium applications and branded players. The company is a Gix Internet Ltd subsidiary.

The enterprise develops an interactive video platform based on the SaaS business model, which has the ability to gather and analyze information about every interactive action performed while a consumer views a video clip. This model enables advertisers to analyze viewing habits of users and increase the effectiveness of live video and online advertising. Its video marketing platform, dubbed Vsense, also enables firms to drive a return on investment from their videos. In addition to this, the enterprise provides solutions that incorporate editing capabilities and templates that allow subscribers to customize their videos with calls to action on various digital platforms.

The firm is focused on establishing itself as a leader in the video content market, which is a multi-billion-dollar industry, and enhancing shareholder value.

ViewBix Inc. (VBIX), closed Wednesday's trading session at $7, up 37.5246%, on 24,504 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.2/$12.

Intrusion (INTZ)

QualityStocks, MarketBeat, Premium Stock Alerts, MarketClub Analysis, Marketbeat.com, InsiderTrades, Zacks, TradersPro, Tim Bohen, PennyOmega, OTCPicks and OTC Markets Group reported earlier on Intrusion (INTZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Intrusion Inc. (NASDAQ: INTZ) is engaged in the provision of network security solutions and services.

The firm has its headquarters in Richardson, Texas and was incorporated in September 1983 by G. Ward Paxton and T. Joe Head. Prior to its name change in November 2001, the firm was known as Intrusion.com Inc. It operates as part of the software and tech services industry, under the technol-ogy sector, in the software sub-industry.

The company specializes in the development and marketing of advanced persistent threat detection, cybercrime, data mining and entity identification products. It serves firms ranging from mid-market to large enterprises, local and state government entities and U.S. federal government entities, via value-added resellers and its direct sales force.

The enterprise’s products include a network monitoring solution known as INTRUSION Savant which identifies suspicious traffic; a data tool which holds an inventory of network enrichments and selectors to support forensic investigations known as INTRUSION TraceCop; and a network detection and response security-as-a-service solution that identifies and stops attacks and ransom-ware dubbed INTRUSION Shield. In addition to this, the enterprise provides post-and pre-sales support services like system installation and technical consulting services, and is involved in the resale of commercially available servers and computers from different vendors.

The global recognition and interest in the firm’s Shield solution has been growing, with the firm recently revealing that is now focused on entering into constructive long-term strategic agreements which will allow the company to achieve its operating objectives, maximize shareholder value and help it grow.

Intrusion (INTZ), closed Wednesday's trading session at $2.01, up 18.2353%, on 1,417,588 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $0.353/$7.34.

MetaVia (MTVA)

Premium Stock Alerts and MarketBeat reported earlier on MetaVia (MTVA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MetaVia Inc. (NASDAQ: MTVA) is a clinical-stage biotechnology firm focused on the develop-ment of pharmaceuticals for the treatment of cardiometabolic illnesses.

The firm has its headquarters in Cambridge, Massachusetts. Prior to its name change in Novem-ber 2024, the firm was known as NeuroBo Pharmaceuticals Inc. It operates as part of the bio-technology industry, under the healthcare sector. The firm serves consumers around the globe.

MetaVia is party to a license agreement with Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726; and Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy, which is in Phase 2a clinical trials evaluating its effectiveness in treating metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trials for the treatment of type 2 diabetes mellitus. It is also developing DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The enterprise's therapeutic programs include NB-01 for the treatment of painful diabetic neu-ropathy; ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; Gemcabene for the treatment of dyslipidemia; and NB-02 for the treat-ment of cognitive impairment.

The company, which recently reported its latest financial results and provided an update on its operations, remains committed to better meeting the needs of patients by delivering safe, effec-tive and sustainable treatments. This is in addition to generating additional shareholder value.

MetaVia (MTVA), closed Wednesday's trading session at $0.6869, up 2.2477%, on 144,938 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.6326/$5.3.

NanoViricides, Inc. (NNVC)

Tip.us, QualityStocks, MissionIR, SmallCapRelations, InvestorBrandNetwork, BioMedWire, SeriousTraders, Stocks to Buy Now, StocksToBuyNow, NetworkNewsWire, SmallCapSociety, Wall Street Resources, StockMarketWatch, TradersPro, Stock Preacher, InvestorSoup, Beacon Equity Research, PennyStocks24, MarketClub Analysis, BUYINS.NET, StockProfessors, SuperStockTips, Jason Bond, Penny Stocks Finder, StockHideout, Penny Stock Craze, Stock Roach, MarketBeat, SmarTrend Newsletters, StocksEarning, PennyStockShark, LightningStockPicks, CoolPennyStocks, Standout Stocks, Stock Analyzer, FeedBlitz, USA Market News, Broad Street, The Daily Market Alert, Market Wrap Daily, StreetAuthority Daily, HotOTC, OTCPicks, Jeff Bishop, Penny Stock Finder, PennyOmega, Smart Investing Society, Small Caps, TopStockAnalysts, ProTrader, Tiny Gems, AllPennyStocks, Agora Financial, InvestorsUnderground, The Online Investor, InvestorPlace, The Street, HotStockChat, CRWEFinance, Greenbackers, DrStockPick, CRWEWallStreet, CRWEPicks, BestOtc, MarketMovingTrends, BullRally, All about trends, Penny Pick Finders, Round Up the Bulls, RedChip, Real Pennies, Stock Beast, ProfitableTrading, PennyTrader Publisher, Zacks, Stock Market Watch, 360 Wall Street, MarketClub, Stock Source, StreetInsider, Penny Invest, OTCReporter, StockEgg, StockHotTips, MicrocapVoice, MicroCapDaily, MegaPennyStocks, SmallCapVoice, Stockwire, PennyToBuck and Stock Rich reported earlier on NanoViricides, Inc. (NNVC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NanoViricides, Inc. (NYSE American: NNVC) has initiated an animal trial to evaluate its clinical-stage antiviral candidate NV-387 for Measles, targeting a rising global health threat amid vaccine failures and declining immunization rates. Using genetically modified mice expressing the human CD150/SLAM receptor required for viral entry, the study aims to confirm NV-387’s potential as the first effective therapeutic for Measles. The drug previously cured lethal RSV infections in animals and is designed to mimic human cell surfaces, neutralizing viruses by binding and dismantling them. With U.S. cases surpassing 1,000 in 2025 and Europe reporting a tenfold increase last year, NanoViricides is positioning NV-387 to fill a critical unmet need as traditional vaccine strategies face mounting challenges.

To view the full press release, visit https://ibn.fm/uaFg2

About NanoViricides Inc.

NanoViricides is a development-stage company that is creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide(TM) class of drug candidates and the nanoviricide(TM) technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments. The company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005. NanoViricides’ lead drug candidate is NV-387, a broad-spectrum antiviral drug that the company plans to develop as a treatment of RSV, COVID-19, Long COVID, influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. The company is currently focused on advancing NV-387 into Phase II human clinical trials. NanoViricides’ other advanced candidate is NV-HHV-1 for the treatment of Shingles. The company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. NV-CoV-2 (“API NV-387”) is the company’s nanoviricide drug candidate for COVID-19 that does not encapsulate remdesivir. NV-CoV-2-R is NanoViricides’ other drug candidate for COVID-19 that is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. For more information about the company, visit www.NanoViricides.com .

NanoViricides, Inc. (NNVC), closed Wednesday's trading session at $1.57, up 6.8027%, on 324,485 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.94/$3.59.

Datavault AI (DVLT)

TechMediaWire, SmallCapRelations, SeriousTraders, QualityStocks, MissionIR, InvestorBrandNetwork, Stocks to Buy Now, Tip.Us, StocksToBuyNow, SmallCapSociety, NetworkNewsWire, AINewsWire, StockWireNews, Jeff Bishop and Fierce Analyst reported earlier on Datavault AI (DVLT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Datavault AI (NASDAQ: DVLT) has signed a strategic licensing agreement with GFT Rewards to deploy its proprietary ADIO(R) inaudible-tone technology across a wide range of high-traffic venues, enabling the real-time delivery and redemption of tokenized or cash-based mobile rewards. GFT Rewards, a leader in Web3 promotions, will use ADIO(R) to power frictionless, passive coupon activation through encrypted audio signals embedded in ads and digital content, helping brands deliver personalized offers to consumers’ mobile devices. As part of the agreement, Datavault will earn a fee per redemption processed through GFT’s expanding platform, which spans airports, retail, entertainment, and ride-hailing networks. With the global mobile coupon market projected to surpass $1.6 trillion by 2030, this partnership places Datavault AI at the forefront of the next generation of performance-based, Web3 retail marketing.

To view the full press release, visit https://ibn.fm/fWJWW

About Datavault AI Inc.

Datavault AI (Nasdaq: DVLT) is leading the way in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI’s Acoustic Science Division features WiSA(R), ADIO(R) and Sumerian(R) patented technologies and industry first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI’s cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange(R) (IDE) enables Digital Twins, licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI’s technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The company is headquartered in Beaverton, OR. Learn more about Datavault AI at www.datavaultsite.com .

Datavault AI (DVLT), closed Wednesday's trading session at $0.911, up 4.2811%, on 459,348 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.6011/$3.7799.

Fusion Fuel Green (HTOO)

QualityStocks, InvestorPlace, MarketBeat, Early Bird, Premium Stock Alerts, MarketClub Analysis, InvestorsUnderground and Green Energy Stocks reported earlier on Fusion Fuel Green (HTOO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Fusion Fuel Green (Nasdaq: HTOO) will hold its Annual General Meeting on June 25, 2025, in Dublin, with shareholders set to vote on six proposals, including a reverse share split of Class A Ordinary Shares at a ratio between 4-to-1 and 40-to-1. The proposed split aims to help the company regain compliance with Nasdaq’s $1.00 minimum bid price requirement. CEO John-Paul Backwell said the move signals continued progress toward long-term sustainability, supported by growth momentum and strategic acquisition opportunities.

To view the full press release, visit https://ibn.fm/9CMtM

About Fusion Fuel Green PLC

Fusion Fuel Green PLC (NASDAQ: HTOO) is an emerging leader in the energy services sector, offering a comprehensive suite of energy engineering and advisory solutions through its Al Shola Gas and BrightHy subsidiaries. Al Shola Gas provides full-service industrial gas solutions, including the design, supply, and maintenance of liquefied petroleum gas (LPG) systems, as well as the transport and distribution of LPG to a broad range of customers across commercial, industrial, and residential sectors. BrightHy, the Company’s newly launched hydrogen solutions platform, focuses on delivering innovative engineering and advisory services that enable decarbonization across hard-to-abate industries.

For more information, visit the company’s website at https://www.fusion-fuel.eu

Fusion Fuel Green (HTOO), closed Wednesday's trading session at $0.293421, off by 2.193%, on 58,879 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $0.205/$1.28.

Cresco Labs Inc. (CRLBF)

QualityStocks, CannabisNewsWire, InvestorPlace, Kiplinger Today, Daily Trade Alert, MarketBeat, Cabot Wealth, Top Pros' Top Picks, The Street, The Wealth Report, Wealth Insider Alert, Trading For Keeps, Trades Of The Day, The Online Investor, Early Bird, Prism MarketView, StreetInsider, wyatt research newsletter, TradersPro and StocksEarning reported earlier on Cresco Labs Inc. (CRLBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Marijuana companies and related businesses are starting to feel the pressure from rising costs triggered by President Donald Trump’s unpredictable tariff policies. The trade actions, which disrupted long-standing global agreements, have raised fears of economic downturn and higher inflation in the U.S., affecting everything from basic supplies to more specialized equipment used throughout the cannabis industry.

Operators across the cannabis space, especially those relying on global supply chains, are facing higher prices on packaging, cultivation tools, raw materials, and product parts. Many companies are already being forced to reconsider where they source their materials, with some now seeking domestic options to sidestep the growing uncertainty overseas.

Some brands and retailers plan to raise their prices to offset these new expenses. They argue that profit margins were already slim due to heavy regulation and taxes, and the added burden from tariffs could tip the balance even more in favor of the unlicensed, underground market.

Trump’s “reciprocal” tariffs targeted countries like those in the EU and Southeast Asia, regions that supply vital gear such as payment systems and raw inputs for cannabis companies. Although he later paused most of these tariffs for 90 days, excluding China, the damage had already begun. China’s exports now face a 145% tariff due to a failed compromise with the U.S., further escalating the trade battle.

A blanket 10% tariff on goods from nearly 90 nations went into effect in early April, causing a sharp drop in U.S. stock markets. This steep decline erased trillions in value over just two days. Although stocks bounced back after the policy was softened, the cannabis sector’s main investment fund still hovered near record lows.

Industry leaders say the financial hit is real. Arnaud Dumas de Rauly, a marijuana consultant and trade group chair, said these new costs are a direct threat to the industry’s growth and profits. “We’re exposed to global supply shocks,” he warned, “and they’re getting more expensive, fast.”

Construction companies working with marijuana firms have seen aluminum, wiring, and security systems jump by as much as 40% in cost. Materials like steel framing and surveillance tools—often imported from Germany and China—are costing significantly more. Procurement is also shifting. Price quotes now expire in just days, and contractors are demanding more upfront money to lock in costs, putting extra strain on company budgets.

Vape brands are hit especially hard. Companies like Pax rely heavily on parts from China, including batteries and devices. Due to overlapping tariffs from both the Trump and Biden administrations, Pax now faces a staggering 150% combined import tax on many of its products. Even alternative manufacturing bases, like Malaysia, are no longer safe from rising trade barriers.

The industry is navigating a new reality: unpredictable tariffs, rising prices, and supply chain disruption. These challenges are forcing operators like Cresco Labs Inc. (CNX: CL) (OTCQX: CRLBF) to adapt quickly and rethink how they do business in an increasingly unstable global trade environment.

Cresco Labs Inc. (CRLBF), closed Wednesday's trading session at $0.51, off by 9.7345%, on 2,441,942 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $0.4931/$2.05.

Strawberry Fields REIT (STRW)

MarketBeat, Schaeffer's, InsiderTrades, Zacks and QualityStocks reported earlier on Strawberry Fields REIT (STRW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Strawberry Fields REIT (NYSE AMERICAN: STRW) has entered into a $59 million purchase and sale agreement to acquire nine skilled nursing facilities in Missouri, totaling 686 licensed beds. The deal, signed on May 22, 2025, will be financed through a combination of working capital and third-party lending.

Eight of the facilities will be leased to the Tide Group under an expanded master lease reset for a new 10-year term, adding $5.5 million in annual rent with 3% annual increases. The ninth facility will be leased to a Reliant Care Group affiliate under a separate master lease reset for 15 years, contributing an additional $0.6 million in rent annually, also with 3% annual bumps. The Company expects to close the transaction by July 1, 2025, though timing is not guaranteed.

To view the full press release, visit https://ibn.fm/dJH9V

About Strawberry Fields REIT

Strawberry Fields REIT, Inc., is a self-administered real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing and certain other healthcare- related properties. The Company’s portfolio includes 132 healthcare facilities with an aggregate of 14,750+ bed, located throughout the states of Arkansas, Illinois, Indiana, Kansas, Kentucky, Michigan, Missouri, Ohio, Oklahoma, Tennessee and Texas. The 132 healthcare facilities comprise 120 skilled nursing facilities, 10 assisted living facilities, and two long-term acute care hospitals.

For more information, visit the company’s website at: https://www.strawberryfieldsreit.com/

Strawberry Fields REIT (STRW), closed Wednesday's trading session at $10.16, off by 1.8357%, on 33,076 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $8.7/$12.9.

LaFleur Minerals (LFLRF)

Investor News reported earlier on LaFleur Minerals (LFLRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) has unveiled plans for a 5,000-meter diamond drill program at its Swanson Gold Project in Québec’s Abitibi Gold Belt, supported by promising exploration results and strategic momentum toward restarting its 100%-owned Beacon Gold Mill by early 2026. The company has identified over 50 drill targets following geophysical surveys, soil sampling, and high-grade grab samples up to 11.7 g/t Au. Additionally, LaFleur announced the appointment of mining executive Peter Espig as Strategic Advisor to support project funding and expansion, leveraging his deep capital markets and mill operations experience. Advanced discussions are underway with institutional and private equity groups to finance the Beacon restart, estimated at C$5–6 million, with the goal of generating near-term cash flow through bulk sampling and toll milling.

To view the full press release, visit https://ibn.fm/9TZXv

About LaFleur Minerals Inc.

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) is focused on the development of district-scale gold projects in the Abitibi Gold Belt near Val-d’Or, Québec. Our mission is to advance mining projects with a laser focus on our resource-stage Swanson Gold Project and the Beacon Gold Mill, which have significant potential to deliver long-term value. The Swanson Gold Project is approximately 16,600 hectares (166 km 2 ) in size and includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. LaFleur has recently consolidated a large land package along a major structural break that hosts the Swanson, Bartec, and Jolin gold deposits and several other showings which make up the Swanson Gold Project. The Swanson Gold Project is easily accessible by road with a rail line running through the property allowing direct access to several nearby gold mills, further enhancing its development potential. Lafleur Minerals’ fully-refurbished and permitted Beacon Gold Mill is capable of processing over 750 tonnes per day and is being considered for processing mineralized material at Swanson and for custom milling operations for other nearby gold projects.

For more information, visit the company’s website at : https://lafleurminerals.com/

LaFleur Minerals (LFLRF), closed Wednesday's trading session at $0.1844, up 56.6695%, on 44,000 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $0.0067/$1.65.

The QualityStocks Company Corner

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlight Nutriband Inc. (NASDAQ: NTRB).

NTRB listed on the Nasdaq in 2021, is trading above its IPO price, and hit an all-time high of $11.78 in January of this year

Nutriband's AVERSA abuse-deterrent patch technology is FDA-bound and could command a market potential as high as $800 million annually

Serguei Melnik, Founder and President of Nutriband (NASDAQ: NTRB) , recently joined The Smart Money Circle Show , where he pulled back the curtain on his no-nonsense approach to biotech entrepreneurship. His grounded tone and unwavering focus on long-term value stand in stark contrast to the conventional biotech playbook.

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

In February 2025, the company formalized its product development partnership with Kindeva Drug Delivery through a long-term exclusive agreement. The collaboration supports the commercial pathway for AVERSA Fentanyl by leveraging Kindeva’s FDA-approved transdermal fentanyl patch system.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl. In subsequent updates, Nutriband confirmed that the NDA submission remains the company’s primary focus and is backed by a strong cash position.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

In support of this commercialization strategy, Nutriband closed an $8.4 million private placement in April 2024 to fund development activities related to AVERSA Fentanyl. The company also licensed Bitrex®, a widely used aversive agent, to enhance the deterrent profile of its patch formulation.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Investment Considerations
  • Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, like fentanyl, while keeping these drugs accessible to patients.
  • AVERSA technology can be incorporated into any transdermal patch.
  • The company has a broad and expanding intellectual property portfolio protecting AVERSA, with patents granted in the U.S., Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China.
  • Nutriband closed an $8.4 million financing round in April 2024 to support commercial development of AVERSA Fentanyl, its abuse-deterrent fentanyl transdermal patch.
  • In February 2025, the company formalized a long-term exclusive partnership with Kindeva Drug Delivery to support AVERSA Fentanyl’s pathway to market.

Nutriband Inc. (NASDAQ: NTRB), closed Wednesday's trading session at $8.18, up 6.096%, on 109 volume. The average volume for the last 3 months is 93,267 and the stock's 52-week low/high is $3.7223/$11.78.

Recent News

Beeline Holdings Inc. (NASDAQ: BLNE)

The QualityStocks Daily Newsletter would like to spotlight Beeline Holdings Inc. (NASDAQ: BLNE).

Beeline Holdings (NASDAQ: BLNE) is expanding its digital mortgage suite with an equity conversion product powered by blockchain-backed stablecoins. Teaming with RealCo, which will acquire up to 49% interest in high-value homes, the program lets homeowners receive immediate funds—without loans or interest—by selling a portion of their equity. RealCo will mint stablecoins tied to the property's recorded fractional ownership, offering flexibility in either cash or token form. The innovation positions Beeline to meet surging demand from non-traditional borrowers while generating consistent, interest-rate-agnostic revenue starting in Q4 2025. To view the full press release, visit https://ibn.fm/7ad5s

Beeline Holdings (NASDAQ: BLNE) is launching a first-of-its-kind home equity access product that allows homeowners to tap into their equity without taking on debt or monthly payments. Set to begin beta transactions in June ahead of a full July rollout, the offering uses RealCo-issued stablecoins backed by fractional property ownership. RealCo, co-owned by Beeline's CEO and principal shareholder, will acquire up to 49% equity in qualifying homes valued at $1 million or more, offering homeowners either cash or stablecoins at closing—repayable only upon property sale. Beeline will handle origination and title services, while RealCo mints coins tied to blockchain-recorded property shares. To view the full press release, visit https://ibn.fm/7ad5s

Beeline Holdings (NASDAQ: BLNE) has announced a disruptive new product that enables equity-rich homeowners to access cash without loans, interest rates, or monthly obligations. Through its partnership with RealCo—an affiliated entity that will issue stablecoins secured by fractional deeds—Beeline provides an alternative to refinancing and HELOCs. With RealCo acquiring minority ownership stakes in luxury homes, this blockchain-based model opens a new liquidity path for homeowners while helping Beeline pursue operational profitability by Q4 2025. The model is not a pivot but an expansion of Beeline's fintech-driven mortgage ecosystem.

To view the full press release, visit https://ibn.fm/7ad5s

Beeline Holdings Inc. (NASDAQ: BLNE) is a technology-forward mortgage and title platform leveraging AI, automation, and intuitive user experiences to simplify home financing. Through wholly owned subsidiary Beeline Loans Inc., the company delivers fast and flexible loan solutions for both primary homebuyers and real estate investors. Beeline has built an end-to-end digital lending ecosystem designed to eliminate friction, reduce costs, and dramatically shorten closing timelines.

Since completing its October 2024 merger with Eastside Distilling, Beeline has solidified its position as a next generation fintech mortgage originator. Its core vision centers on digitizing the mortgage journey with tools like AI chatbot Bob, proprietary production engine Hive, and an expanding SaaS product suite. These innovations enable Beeline to close loans in just 14–21 days—less than half the industry average—while achieving a Net Promoter Score above 80, more than four times higher than the sector benchmark.

Beeline’s mission is to make home loans effortless by giving users instant access to rate quotes, approvals, and document uploads—all online, 24/7. Having surpassed $1 billion in cumulative loan originations and achieved 38% year-over-year growth, Beeline is scaling its platform across the U.S. mortgage and real estate investing landscape.

The company is headquartered in Providence, Rhode Island.

Products

Beeline operates a fully digital, AI-enabled loan origination and title ecosystem. Key features include:

  • Bob 2.0 – The industry’s first AI mortgage agent, available 24/7/365 to quote rates and pre-approve borrowers; Bob has delivered 6x lead conversion and 8x full application volume compared to traditional loan officers.
  • Hive – A task-based processing engine that replaces manual workflows with scalable automation, cutting loan closing times to as little as 14 days.
  • BlinkQC – Beeline’s proprietary AI quality control platform that replaces costly third-party reviews.
  • Beeline Title – A fully diversified title services unit supporting digital collateral transfer, remote closings, and investor-focused solutions.
  • MagicBlocks – A customizable AI sales agent platform developed by Beeline and spun out into its own entity; Beeline retains equity and licensing rights, positioning it to benefit from future growth and deployment of the technology.

The company also provides Debt Service Coverage Ratio (DSCR), bank statement, and conventional mortgage products tailored to investors, including short-term rental operators. Strategic partnerships with Rabbu and Red Awning streamline property analysis, financing, and management within a single ecosystem.

Market Opportunity

The U.S. mortgage market is poised for growth in 2025, with total mortgage origination volume expected to increase by 28% to $2.3 trillion, up from $1.79 trillion in 2024. This projection includes a 13% rise in purchase originations to $1.46 trillion.

Within this expanding market, investor lending, particularly through DSCR loans, represents a rapidly growing segment. DSCR loans, which are underwritten based on the income generated by the property rather than the borrower’s personal income, are ideal for real estate investors, particularly those purchasing long-term or short-term rental properties. Beeline has strategically positioned itself in this niche, with over one-third of its volume derived from DSCR products. Through its affiliate referral network and integrations with platforms like Rabbu, the company is actively expanding its market reach in this high-margin category.

Non-agency mortgage issuance, which includes DSCR loans, is projected to reach $160 billion in 2025, a 16% increase from 2024.

Leadership Team

Nick Liuzza, Chief Executive Officer, co-founded Beeline Mortgage LLC in 2019 after selling Linear Title & Closing and Linear Settlement Services to Real Matters. He also previously built New Age Nurses into a national staffing firm. He currently serves as EVP of Real Matters (TSX: REAL).

Jess Kennedy, Chief Operating Officer, is a co-founder of Beeline with 15 years of legal and real estate experience. She previously served as General Counsel and Chief Compliance Officer at Beeline and held roles at Solidifi, LeClairRyan, and Edwards Wildman Palmer LLP, handling complex real estate finance and title transactions.

Chris Moe, Chief Financial Officer, joined Beeline in 2023 with over 40 years of finance and investment banking experience. He has held senior roles at Red Cat Holdings (NASDAQ: RCAT), IRIS Therapeutic Devices, and Yates Electrospace Corporation, bringing deep public company and defense sector expertise.

Investment Considerations
  • Beeline has surpassed $1 billion in loan originations and achieved 38% year-over-year growth in 2024.
  • The company offers a unique tech stack, including AI chatbot Bob, the Hive engine, and BlinkQC, which drives faster and more affordable closings.
  • Beeline is strongly positioned in DSCR and investor lending markets through strategic partnerships with platforms like Rabbu and Red Awning.
  • The expansion of Beeline Labs and the spinout of MagicBlocks creates new SaaS-based revenue opportunities.
  • Beeline’s leadership team brings a combination of public company experience and deep domain expertise in real estate, fintech, and AI.

Beeline Holdings Inc. (NASDAQ: BLNE), closed Wednesday's trading session at $0.8917, up 0.8026227%, on 47,015 volume. The average volume for the last 3 months is 603,403 and the stock's 52-week low/high is $0.8166/$29.8.

Recent News

Brera Holdings PLC (NASDAQ: BREA)

The QualityStocks Daily Newsletter would like to spotlight Brera Holdings PLC(NASDAQ: BREA).

Brera Holdings (NASDAQ: BREA) congratulated portfolio club SS Juve Stabia Srl on its fifth-place regular season finish and semifinal run in the Serie A promotion playoffs, as the city of Castellammare di Stabia held a celebratory ceremony recognizing players, staff, and leadership. Brera, a global sports club owner via its multi-club strategy, also acknowledged the regional government's €5 million subsidy commitment to upgrade the team's Romeo Menti Stadium. Executive Chairman Dan McClory praised Juve Stabia's achievement and affirmed Brera's pride in supporting "the pride of Castellammare di Stabia."

To view the full press release, visit https://ibn.fm/l5ikr

Brera Holdings PLC (NASDAQ: BREA) is an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership approach. The company capitalizes on opportunities to earn tournament prizes, secure sponsorships, collect transfer fees, provide professional sports consulting services, and enhance the valuation of its clubs.

Brera Holdings builds on the legacy of Brera FC, an international football club (referred to as soccer in the U.S.), that it acquired in July 2022. Established in 2000 and based in Milan, Italy, Brera FC has distinguished itself by cultivating an alternative football legacy. In October 2024, the Internet Marketing Association awarded Brera FC with the Social Impact Through Soccer accolade at its IMPACT 5050 Conference, recognizing the club’s global perspective and positive contributions to society.

The company’s growth strategy focuses on unlocking value from undervalued sports clubs and talent, driving innovation, and generating socially impactful outcomes. Brera Holdings is actively expanding its Global Sports Group, acquiring professional football and other sports clubs in emerging markets such as Africa, Asia, and Europe.

By targeting top-division teams in less mainstream markets, Brera Holdings aims to strengthen its competitive position in regional tournaments, including those organized by the Union of European Football Associations (UEFA). These acquisitions are expected to enhance sponsorship revenues and create new growth opportunities.

Leveraging its expertise in capital raising and revenue generation, Brera Holdings also anticipates growing demand for its consulting services, providing advisory support to sports clubs, associations, investors, and others. Brera Holdings is headquartered in Dublin, Ireland, with additional offices in Milan, Italy.

Sporting Assets

Brera Holdings continues to grow its global sports portfolio with a series of strategic acquisitions and innovations, including the FENIX Trophy Tournament, a pan-European, non-professional football competition. Launched in September 2021 and organized by Brera FC, the tournament has been recognized by UEFA and described by BBC Sport as “the Champions League for amateurs.” In 2023, Brera FC hosted the tournament’s finals at Milan’s iconic San Siro Stadium.

In March 2023, Brera Holdings expanded into Africa by establishing Brera Tchumene FC in Mozambique. Starting in the country’s Second Division League, the team quickly earned promotion to Moçambola, Mozambique’s First Division League, by November 2023.

In April 2023, Brera Holdings further strengthened its European presence by acquiring a 90% stake in Fudbalski Klub Akademija Pandev, a first-division football team in North Macedonia. This acquisition provides access to two major UEFA competitions, solidifying the company’s position in European football.

Brera Holdings’ reach extends beyond football. In July 2023, it acquired majority ownership of UYBA Volley, an Italian Serie A1 women’s professional volleyball team, demonstrating its commitment to diversifying within top-tier sports.

In September 2023, Brera Holdings entered the Mongolian football market by acquiring Bayanzurkh Sporting Ilch FC, a Mongolian National Premier League team. For the 2024 season, the club was rebranded as Brera Ilch FC, further expanding Brera’s global footprint.

In January 2024, Brera Holdings initiated a proactive search for an Italian Serie B football club, aligning with its goal of bringing multi-club ownership opportunities to mass investors through its Nasdaq-listed shares.

In February 2024, the Brera Holdings Advisory Board was established with MLS founder and World Cup director Alan Rothenberg, luxury lifestyle executive Massimo Ferragamo, sports business leaders Paul Tosetti and Marshall Geller, and Italian football icon Giuseppe Rossi.

In June 2024, the North Macedonian women’s football club Tiverija Strumica officially became part of the Brera family with the establishment of a joint-stock company controlled by Brera Holdings called Women’s Football Club Tiverija Brera AD Strumica (“Brera Tiverija”). Brera Tiverija is now a wholly-owned subsidiary of Brera Strumica FC.

In September 2024 Brera announced that it signed an exclusive letter of intent to acquire an Italian Serie B club (the “LOI” and the “Club”). According to a CFA report published in June 2024, this expected strategic transaction, for an estimated purchase price of $21.6 million, would add first-year annual revenue of $10.8 million to Brera, and that revenue would likely increase by 25% each year for the next three years. The company’s capital valuation, projected the report, would also experience significant appreciation during this period.

In October 2024, Brera was recognized with the 2024 Social Impact Through Soccer Award at IMPACT 5050, an annual event honoring leaders and innovators who significantly impact their industries and communities. This is the second time Brera has won the award.

Market Opportunity

A report from IMARC Group, a global management consulting firm, reveals that the international football market generated approximately $3.3 billion in revenue in 2023, with projections to grow to $4.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 3.6%. Key drivers behind this growth include advancements in digitization, increasing sponsorship and partnership deals between brands and clubs, the rising interest in women’s professional soccer leagues, and the expansion of the e-sports and gaming sector.

In particular, Serie B Italian football clubs seem to present exceptionally attractive investment opportunities. As of September 2024, more than half of these clubs had appreciated between 80-100% in total market value, post-purchase.

As the world’s most-watched and most-played sport, soccer drives significant demand for football-related products and services, contributing to market growth. Broadcasting rights, sponsorships, and endorsement deals are also major revenue sources for clubs and organizations, with an expanding global fanbase generating new opportunities for financial growth, according to the report.

Management Team

With extensive experience in leadership and finance, Daniel McClory currently serves as the Executive Chairman and Director of Brera Holdings, PLC. He co-founded and held the position of Chief Executive Officer at Boustead & Company Limited, and previously served as the Managing Director, Head of Equity Capital Markets, and Head of China at Boustead Securities, LLC. Mr. McClory’s governance experience includes being a Board Director for USA Track & Field and a member of the Eastern Michigan University Champions Advisory Board. Mr. McClory’s expertise encompasses founding and financing equity capital markets, as well as navigating merger and acquisition transactions and initial public offerings. He holds a BS and MS from Eastern Michigan University, where he also received an honorary Doctor of Public Service. In addition to his professional qualifications, he is fluent in both English and Italian.

Pierre Galoppi serves as the CEO, Interim CFO, and director of Brera Holdings. With over 30 years of experience in strategic business and financial services, his career spans a variety of industries, including natural resources, aviation, cybersecurity, telecommunications, tourism, and international marketing. He has worked extensively across Latin America, the Caribbean, Canada, Europe, and the United States. Mr. Galoppi holds dual citizenship in Canada and Italy and is fluent in English, Spanish, Portuguese, Italian, and French. He earned a Bachelor of Commerce degree and an MBA from Concordia University in Montreal.

Maria Xing serves as the Head of Investments and Corporate Development. She is an executive who has specialized in MCO football (soccer) group investments for 777 Partners, where she was involved in sourcing, direct negotiations, due diligence, and closing deals, including acquiring a controlling stake in Brazilian Serie A football club, Vasco da Gama, and investing in Australian Premier League (“A-League”) side, Melbourne Victory FC. She also played a role in other professional sports franchise portfolio management, including topflight professional football clubs in Italy, France, Germany, and Belgium. Her background is in private equity, investment banking, and finance, with prior experience at The Raine Group, Credit Suisse, and EY (Ernst & Young), as well as previous sports industry experience at Liverpool Football Club in international business development. Ms. Xing earned an MBA from the Wharton School of the University of Pennsylvania and a B.S. from the New York University, Stern School of Business.

Additional Resources

Brera Holdings PLC (NASDAQ: BREA), closed Wednesday's trading session at $0.7033, up 5.2844%, on 2,384 volume. The average volume for the last 3 months is 73,330 and the stock's 52-week low/high is $0.4999/$1.95.

Recent News

Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF)

The QualityStocks Daily Newsletter would like to spotlight Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF).

Nicola Mining (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) has appointed Vicente García as Senior Geologist to support its upcoming 2025 exploration initiatives, particularly at the New Craigmont copper project. García brings over seven years of global experience across porphyry, IOCG, epithermal, and lithium systems, with recent roles at Anglo American and Dahrouge Geological Consulting. CEO Peter Espig emphasized the company's continued focus on copper exploration, noting that García and VP of Exploration Will Whitty will also evaluate targets at the fully permitted Treasure Mountain Silver Mine.

To view the full interview, visit https://ibn.fm/QPvDT

Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) is a junior resource company focused on monetizing high-grade mineral assets in British Columbia. With a unique dual-pronged model, the company combines solid operational revenues from its wholly-owned, state-of-the-art gold and silver mill with the long-term upside of 100%-owned copper, silver, and gold exploration projects. This approach allows Nicola to fund ongoing development while minimizing equity dilution.

The company’s strategy centers on aligning infrastructure and permitting advantages with mineral-rich geology, positioning it to process its own, as well as third-party high-grade gold and silver mines via partnerships, to advance its own exploration targets. Key agreements with gold producers and concentrating sales contracts provide stable cash flow, making Nicola rare among juniors in its ability to internally support growth. Its solid balance sheet and business acumen have allowed it to take stakes in other near-term gold producers, including a 75% economic stake in Dominion Gold, which commences a bulk sample in 2H 2025.

Nicola is leveraging its platform of permitted infrastructure, strategic project locations, and deep technical expertise to build shareholder value in a low-risk, high-reward framework. The company is headquartered in Vancouver, British Columbia.

Projects

Nicola Mining’s project portfolio includes high-grade copper, silver, and gold assets located in mineral-rich regions of British Columbia. Each project is 100%-owned or majority-controlled, with strong exploration potential and the necessary permits to advance development.

New Craigmont Copper Project

Nicola’s flagship asset, the New Craigmont Project, is a historic producer of over 900 million pounds of copper. Since acquiring 100% ownership in 2015, the company has drilled over 18,000 meters and identified significant skarn-hosted and porphyry-style mineralization. Recent drilling in 2024 confirmed 52.9 meters at 1.03% Cu (Hole NC-24-002), supporting the presence of a large-scale copper system. The project benefits from paved road access, connection to BC Hydro’s grid, and proximity to urban centers.

Treasure Mountain Silver Project

This 100%-owned past-producing mine has a Major Mines permit (M-239) and an NI 43-101 compliant resource estimate. The site includes multiple silver-lead-zinc veins and is permitted to extract up to 60,000 tonnes annually. Nicola is evaluating potential reactivation or joint venture options. Resource estimates include indicated resources of 52,000 tonnes grading 18.1 oz/t Ag, 3.26% Pb, and 3.4% Zn, and inferred resources of 161,000 tonnes grading 22.0 oz/t Ag, 2.48% Pb, and 3.86% Zn.

Dominion Creek Project (Au-Ag)

Nicola holds a 50% land ownership and 75% economic stake in this gold-silver project. Located 43 km from Wells, British Columbia, the site has returned grab samples averaging 61.3 g/t Au and 173.7 g/t Ag. The company has received its final permit and plans to extract a 10,000-tonne bulk sample in 2025, which will be processed at its Merritt Mill facility.

Operations

In addition to its exploration assets, Nicola Mining operates a suite of permitted industrial facilities in British Columbia that generate revenue and support the company’s broader development strategy. These assets form the backbone of Nicola’s self-sustaining business model.

Merritt Mill & Tailings Facility

Nicola owns and operates British Columbia’s only provincially permitted toll mill for gold and silver, a $30 million flotation facility located near Merritt. Gold production began in 2023. The facility is supported by long-term Milling and Profit Share Agreements with companies including Osisko Development Corporation, Blue Lagoon Resources, and Talisker Resources.

Sand & Gravel Pit / Rock Quarry / Ready-Mix Concrete Plant

Nicola also operates a permitted gravel pit (100,000 t/year), rock quarry (1,500 t/day), and is set to launch a ready-mix cement plant in Q2 2025. These operations, run in partnership with local First Nations, generate stable cash flow to support exploration efforts.

Market Opportunity

Nicola Mining is uniquely positioned in southern British Columbia, a jurisdiction recognized for its mining-friendly policies, skilled labor force, and robust infrastructure. The New Craigmont Project is geologically situated within the Guichon Creek Batholith, a region hosting some of Canada’s largest copper mines, including Highland Valley. Exploration data from 2023 and 2024 support the potential presence of both skarn and porphyry systems, increasing the strategic value of Nicola’s holdings.

The company’s other assets, including Treasure Mountain and Dominion Creek, are located in historically productive areas with high-grade mineralization and established access routes. Dominion Creek, in particular, sits atop the Isaac Lake Fault system—identified in British Columbia’s RGS (Regional Geochemical Survey) as a highly anomalous gold-silver corridor. Nicola’s integrated production model enables it to generate revenue while advancing these exploration programs without excessive dilution, providing a distinct advantage in a volatile commodities market.

Leadership Team

Peter Espig, Chief Executive Officer & Director, is a former diamond driller who spearheaded Nicola through a restructuring into its recent growth. He brings over $2 billion in private equity transaction experience, is a pioneer of SPACs, and has held senior positions at Goldman Sachs Japan and Olympus Capital.

Will Whitty, VP of Exploration, brings to the company over 15 years of experience in copper and gold exploration. He previously worked at Freeport-McMoRan and Nevada Gold Mines. He holds a master’s degree from the Mineral Deposit Research Unit (MDRU) at the University of British Columbia.

Bill Cawker, Corporate Development, manages investor relations, communications, and corporate governance. He joined Nicola in 2023 and brings extensive small-cap public markets experience, along with a degree in economics from the University of British Columbia.

Sam Wong, Chief Financial Officer, is a CPA with over 18 years of experience in the mining sector. He previously held executive roles at several publicly listed resource companies. He began his career at Deloitte LLP in Vancouver.

Investment Considerations
  • High-Grade Copper Opportunity: 100% ownership of the New Craigmont Project, one of British Columbia’s most promising high-grade copper exploration targets, strategically located adjacent to Canada’s largest copper mine (Highland Valley Copper).
  • Immediate Revenue Generation: Operates British Columbia’s only permitted mill capable of processing third-party gold and silver ore, with current throughput supporting strong, near-term cash flow.
  • Diverse Revenue Streams: Revenue growth fueled by commercial milling operations, gold concentrate sales, and active aggregate production — providing self-funded exploration and reducing reliance on capital raises.
  • Strategic Location & Infrastructure: Centrally located near major transportation routes and mining services, providing cost advantages and operational efficiencies.
  • Proven Leadership Team: Led by a management group with extensive track records in mining operations, project development, and capital markets, driving disciplined growth and long-term value creation.

Nicola Mining Inc. (OTCQB: HUSIF), closed Wednesday's trading session at $0.3238, up 1.1875%, on 9,600 volume. The average volume for the last 3 months is 133,300 and the stock's 52-week low/high is $0.1498/$0.33.

Recent News

ONAR Holding Corp. (OTCQB: ONAR)

The QualityStocks Daily Newsletter would like to spotlight ONAR Holding Corp. (OTCQB: ONAR).

ONAR (OTCQB: ONAR) , a next-generation, technology-first network of marketing and creative services agencies, was recently featured in a Digital Journal Q&A discussing how the company accelerates performance for middle-market businesses. The interview highlights ONAR's unique blend of strategic services, AI-driven insights, and scalable execution.

In the discussion, CEO Claude Zdanow explains how ONAR bridges the gap for middle-market firms, combining enterprise-level marketing expertise with the agility and efficiency these businesses need to scale. He emphasizes the role of speed, flexibility, and partnership in aligning AI and technology with each client's growth goals.

To read the full interview, visit: https://ibn.fm/6PfpC

ONAR Holding Corp. (OTCQB: ONAR) is a leading marketing technology company and marketing agency network focused on delivering integrated, AI-driven solutions to accelerate revenue growth for its clients. Through an agile agency network specializing in performance marketing, full-service healthcare marketing, experiential marketing, and technology incubation, ONAR provides best-in-class services to a growing roster of clients worldwide.

Built on a foundation of innovation and operational excellence, ONAR’s vision is to redefine marketing services by leading with technological advancement. With employees across five continents, the company is aggressively expanding its team to support both organic growth and an active acquisition pipeline. ONAR’s strategic growth model focuses on growing and acquiring proven agencies under one umbrella to deliver superior service offerings across industries.

ONAR’s mission is to drive measurable client success through integrated, high-impact marketing solutions that blend creativity, data science, and technology. As it continues to expand, ONAR is focused on building a global marketing services network that serves companies ranging from $10 million to $300 million in revenue.

The company is headquartered in Miami, Florida.

Portfolio

ONAR’s operations are organized across a network of specialized agencies that together serve more than 45 clients across a wide range of industries. Each agency brings deep domain expertise and a results-driven approach:

  • Storia: A premier performance marketing agency specializing in brand growth, paid media, and SEO. With a focus on data-driven excellence, Storia delivers highly targeted marketing strategies that maximize ROI across digital platforms. The agency partners with leading brands to drive measurable revenue outcomes and long-term brand equity.
  • Of Kos: A full-service healthcare marketing agency committed to redefining the patient experience. Of Kos partners with healthcare professionals to deliver integrated campaigns that not only increase patient engagement but also elevate the standard of care across the healthcare landscape. Its work bridges marketing innovation and healthcare expertise to create real impact.
  • CHALK: An experiential marketing agency that transforms bold ideas into unforgettable, immersive experiences. CHALK’s team of event architects specializes in designing events that break boundaries — from brand activations and pop-ups to major corporate experiences — creating lasting emotional connections between brands and audiences.
  • ONAR Labs: The company’s pioneering technology incubator, ONAR Labs, brings together data scientists, engineers, and industry experts to develop proprietary marketing technologies. Every product is rigorously battle-tested within the agency network before commercialization, ensuring that ONAR Labs delivers real-world solutions that enhance marketing performance and client success.

Market Opportunity

ONAR operates at the intersection of marketing services and marketing technology, two sectors undergoing rapid evolution and expansion. The global digital marketing software market alone is projected to reach $264.15 billion by 2030, expanding at a CAGR of 19.4%, according to Grand View Research. Meanwhile, healthcare marketing and experiential marketing are experiencing renewed momentum, as companies seek to create more personalized and immersive customer experiences.

With its integrated, AI-driven platform and expertise across multiple high-growth verticals, ONAR is well positioned to capture a growing share of the marketing spend from mid-sized to large enterprise clients. As businesses increasingly prioritize digital transformation, customer experience, and data-driven marketing, ONAR’s diversified offerings and proprietary technologies through ONAR Labs create meaningful competitive advantages in a highly fragmented market.

Leadership Team

Claude Zdanow, Chief Executive Officer, is a seasoned entrepreneur and business leader with deep experience scaling service organizations and technology platforms. Prior to founding ONAR, he built and successfully exited multiple companies in marketing and media, combining creative vision with operational discipline to drive measurable client growth.

Chris Becker, President, brings extensive operational and strategic expertise to ONAR, focusing on driving agency performance and expanding the company’s integrated service offering. His leadership emphasizes operational rigor, client success, and scaling the company’s footprint across industries and regions.

Patricia Kaelin, Chief Financial Officer, oversees ONAR’s financial operations and strategic planning. A distinguished financial executive with more than 25 years of experience in scaling high-growth companies and leading finance teams at both public and private companies, she expertly manages financial strategy, M&A transactions, and provides a strong foundation for ONAR’s continued expansion and acquisition initiatives.

Sam Mendez, Chief of Staff, fosters seamless collaboration across the organization. She expertly manages strategic projects, facilitates clear communication channels, and acts as a key point of contact to maximize the executive team’s impact and advance organizational goals.

Investment Considerations
  • ONAR is scaling a diversified, AI-driven marketing network addressing multiple high-growth industry verticals.
  • The company is actively pursuing an acquisition-driven expansion strategy to grow its marketing agency network.
  • ONAR Labs provides a proprietary technology pipeline, offering additional revenue streams beyond traditional marketing services.
  • A strong leadership team with proven track records in business growth, financial management, and technology commercialization positions the company for long-term success.
  • ONAR’s focus on middle market and growth-stage clients aligns with sectors expected to see a sustained rise in marketing spend over the next decade.

ONAR Holding Corp. (OTCQB: ONAR), closed Wednesday's trading session at $0.05, even for the day, on 10,167 volume. The average volume for the last 3 months is 5,540 and the stock's 52-week low/high is $0.03/$0.167.

Recent News

Adageis

The QualityStocks Daily Newsletter would like to spotlight Adageis

Adageis, a growing healthcare technology company, offers a unique streamlined and AI-powered software solution designed to make the shift toward value-based care simpler for healthcare practices. "At the core of the company's offering is the ProActive Care Platform, a patented, AI-centric engine that enables providers, health systems, ACOs, and CINs to identify and act on high-value opportunities within their existing operations," reads a recent article. "What sets Adageis apart is ease of use, giving practices clear, actionable insights on where value lies, and how to pursue it while maintaining or improving quality of care."

To view the full article, visit https://ibn.fm/pxHBp

Adageis is a healthcare technology company dedicated to revolutionizing patient care through innovative solutions. By integrating artificial intelligence (AI) and machine learning, Adageis addresses inefficiencies in healthcare delivery, enabling providers to enhance patient outcomes and streamline operations. The company focuses on leveraging advanced technology to meet the growing demand for value-based care and quality incentives in the healthcare sector.

With a commitment to innovation and practical solutions, Adageis empowers clinics, healthcare centers, and care networks to implement its ProActive Care Platform without the need for expensive platform changes or extensive staff training. This approach reduces barriers to adoption and helps healthcare organizations maximize their potential in an increasingly complex industry landscape.

Recent collaborations, including its partnership with HealthyU Clinics and integration with AthenaHealth as a marketplace partner, underscore Adageis’s industry relevance and adaptability.

Adageis is headquartered in Mesa, Arizona.

Services

Adageis offers the ProActive Care Platform, an AI-driven solution designed to integrate seamlessly with existing Electronic Medical Records (EMR) systems.

This platform enables healthcare providers to deliver patient-centric care while maximizing reimbursements from quality metrics and value-based contracts. Key features include:

  • Predictive Analytics: Utilizes AI to analyze patient data, identifying high-risk individuals and care gaps to improve health outcomes and reduce costs.
  • Efficiency and Cost Reduction: Continuously monitors patient health, allowing providers to offer proactive care even outside traditional office visits, thereby enhancing efficiency and lowering expenses.
  • Flexible Integration: Compatible with various EMR systems, including AthenaHealth, Cerner, eClinicalWorks, Allscripts, and Epic, facilitating easy adoption without the need for extensive staff training or platform changes.

Market Opportunity

The global AI in healthcare market is experiencing rapid growth, driven by the increasing demand for enhanced efficiency, accuracy, and better patient outcomes. In 2023, the market was valued at approximately $19.27 billion by Grand View Research, and it is projected to grow at a compound annual growth rate of 38.5% from 2024 to 2030. This growth is fueled by the increasing need for solutions that can analyze large datasets, reduce costs, and improve care delivery across the healthcare continuum.

Adageis is well-positioned to capitalize on these trends. Its ProActive Care Platform offers AI-driven predictive analytics and proactive care solutions that align with the industry’s shift toward value-based care. By providing seamless integration with existing EMR systems and focusing on operational efficiency, Adageis enables healthcare providers to meet the demands of a rapidly evolving market.

Leadership Team

Shane Speirs, MD, MBA serves as the company’s CEO. He is a board-certified physician in family and geriatric medicine with extensive experience in healthcare leadership, data modeling, and AI applications in healthcare delivery. He holds an MBA in Healthcare Management from the W.P. Carey School of Business and has a proven track record in managing telehealth and AI-focused healthcare companies.

Bill Jentarra, MBA is the CTO of Adageis, bringing over 25 years of experience in architecting and implementing complex client relationship management (CRM) and business intelligence (BI) solutions across various industries, including healthcare. His expertise encompasses the entire lifecycle of CRM and BI projects, ensuring practical and cost-effective technology applications to solve complex business problems.

Recent News

chart

Massimo Group (NASDAQ: MAMO)

The QualityStocks Daily Newsletter would like to spotlight Massimo Group (NASDAQ: MAMO).

Massimo Group (NASDAQ: MAMO) announced a strategic shift to nearshoring its manufacturing operations, reducing reliance on East Asia and positioning new production capabilities closer to core North American markets. The move aims to mitigate global shipping risks, improve inventory control, and enhance gross margins while supporting the rollout of next-gen electric and climate-controlled UTVs and ATVs. CEO David Shan said the investment reflects Massimo's commitment to operational agility and long-term growth, with the transition expected to improve lead times, ESG performance, and responsiveness across its dealer network.

To view the full press release, visit https://ibn.fm/8eji8

Massimo Group (NASDAQ: MAMO) is a prominent manufacturer and distributor specializing in powersports vehicles and recreational watercraft. Established in 2009, the company has built a reputation for delivering value-packed utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), and on-road vehicles to both recreational enthusiasts and professionals in the agricultural sector. In 2020, Massimo expanded its offerings by launching Massimo Marine, dedicated to crafting high-quality watercraft with advanced designs and exceptional customer service.

Massimo Group is focused on sustainability. Its recent initiatives, including the introduction of the MVR Series of electric carts, highlight the company’s commitment to eco-friendly solutions that address growing consumer demand for sustainability in the powersports and marine industries.

The company’s manufacturing capabilities have also evolved significantly. Its expanded 376,000-square-foot facility in Garland, Texas, now features advanced automation, including a vehicle assembly robot line. This addition is expected to significantly enhanced production capacity and efficiency, enabling Massimo to scale its operations and better meet market demand.

Product Portfolio

Massimo Group’s product portfolio showcases its dedication to innovation and versatility. Its diverse lineup combines advanced features, sustainability, and value to meet the needs of a dynamic market.

  • Massimo Motor: This category includes a wide range of UTVs, ATVs, go-karts, and mini-bikes designed for both recreational and practical applications. Notable recent additions include the T-Boss 1000 UTV, which combines rugged performance with advanced features, and the GKD 350 All-Terrain Go-Kart, a versatile two-seater ideal for various terrains. The Buck 550-6 Crew, a six-seater UTV, further expands this lineup, providing comfort and utility for families and light-duty users at an accessible price point.
  • Massimo Marine: Specializing in pontoon and tritoon boats, this division emphasizes luxury and performance. A recent collaboration between Massimo and Vision Marine Technologies has introduced electric pontoon platforms, catering to consumers seeking eco-friendly watercraft for both commercial and recreational use.
  • Massimo Electric: Reflecting the company’s commitment to sustainability, Massimo Electric focuses on low-speed electric vehicles (LSVs) tailored for diverse applications. Recent launches include the MVR 2X Golf Cart and MVR Cargo Max Utility Cart, which deliver advanced features and versatility for recreational users and professionals in industries like farming and groundskeeping.

By combining practicality with cutting-edge design, Massimo Group seeks to set the standard in the powersports and marine industries.

Market Opportunity

The global ATV and UTV market is experiencing robust growth, with North America projected to reach approximately $9.18 billion in 2024 and expand at a compound annual growth rate (CAGR) of 7.8% to $13.37 billion by 2029, according to Mordor Intelligence. Likewise, the U.S. electric UTV and ATV powertrain market is rapidly expanding. It was valued at $2.46 billion in 2022 and is expected to grow at a CAGR of 10.2%, reaching $5.18 billion by 2030, as reported by Grand View Research.

The pontoon boat market complements this growth, driven by increased interest in leisure and marine tourism. The market size exceeded $7.9 billion in 2022 and is projected to grow at a CAGR of 8.3% through 2032, according to Global Market Insights. Massimo Marine’s introduction of electric pontoon platforms through its Vision Marine partnership is expected to position the company to effectively address this growing market segment.

With strategic partnerships and an expanding dealer network, Massimo believes it is poised to penetrate deeper into domestic and international markets. The company’s service coverage currently includes over 2,800 retail locations, 600 motor service centers, and 5,500 marine service centers, ensuring robust support and accessibility for customers. This extensive distribution network underpins Massimo’s ability to capture market share and drive sustained growth.

Leadership Team

David Shan, Founder, Chairman, and CEO, established Massimo Motor in 2009 and Massimo Marine in 2020. He has led the company through significant growth phases, including the development of diverse product lines and its public listing. Shan holds a bachelor’s degree in international trade from Qingdao Ocean University of China.

Dr. Yunhao Chen, CPA, serves as the company’s Chief Financial Officer, bringing extensive experience in capital markets, financial reporting, and corporate governance since her appointment in May 2023. She holds a Ph.D. in Accounting and an MBA in Finance from the University of Minnesota.

Michael Smith, Vice President, joined Massimo in 2019 and played a pivotal role in launching Massimo Marine. With a strong background in powersports retail and product innovation, he is dedicated to driving new product development. Smith studied International Business and Marketing at the University of California, San Diego.

Investment Considerations
  • Massimo Group operates within a large and growing total addressable market that’s projected to surpass $18 billion by 2026.
  • The company’s cost-competitive and feature-rich products, including all-electric offerings, provide a strong value proposition.
  • Recent automation initiatives at its Texas factory are expected to improve manufacturing efficiency by an estimated 50%.
  • During the first three quarters of 2024, revenue increased by 20.8% to $91.2 million compared to the same period in 2023, reflecting strong market demand and successful product launches.
  • Strategic partnerships, such as those with Vision Marine and Rural King, enhance Massimo’s market reach and growth opportunities.
  • Consistent innovation, as seen in the launches of the T-Boss 1000 and MVR Series, is expected to drive Massimo’s push to be a leader in its industry.

Massimo Group (NASDAQ: MAMO), closed Wednesday's trading session at $2.1, off by 5.5458%, on 16,542 volume. The average volume for the last 3 months is 5,232 and the stock's 52-week low/high is $2.06/$4.6599.

Recent News

Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

Soligenix (SNGX) is spotlighting new interim data on HyBryte(TM) (synthetic hypericin) for early-stage cutaneous T-cell lymphoma (CTCL) in a recent podcast hosted by the Cutaneous Lymphoma Foundation. Featured guest Dr. Ellen Kim, Principal Investigator of the ongoing investigator-initiated study and Director of the Penn Cutaneous Lymphoma Program, reported a 75% treatment success rate at 18 weeks and up to 85% improvement in patients treated through 54 weeks. The study builds on prior results from the Phase 3 FLASH trial and mirrors the design of the current FLASH2 confirmatory trial, now enrolling patients. Dr. Kim emphasized HyBryte's safety and tolerability, with no serious side effects reported and only one patient dropout due to logistical reasons.

Designed to reflect real-world clinical practice, the open-label study eliminates rest periods and extends treatment duration—approaches that appear to boost efficacy. In the podcast, Dr. Kim underscored the limitations of existing skin-directed therapies and the urgent need for new options, particularly for early-stage CTCL. With its non-mutagenic mechanism and rapid response time, HyBryte is emerging as a potentially safer, faster-acting alternative to traditional treatments like steroids, chemotherapy, and phototherapy, offering renewed hope for patients with this chronic and underserved cancer.

To view the podcast, visit https://ibn.fm/sCfYo

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Investment Considerations
  • Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals.
  • The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications.
  • Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives.
  • The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease.
  • Soligenix is led by an experienced management team with a strong track record of success.

Soligenix Inc. (NASDAQ: SNGX), closed Wednesday's trading session at $1.9, off by 2.5641%, on 21 volume. The average volume for the last 3 months is 18,070 and the stock's 52-week low/high is $1.68/$14.8299.

Recent News

SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)

The QualityStocks Daily Newsletter would like to spotlight SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN).

Toyota, long recognized for revolutionizing hybrid cars with the launch of the Prius, has not always kept pace in the fully electric vehicle market. However, that narrative may be shifting. With its latest innovation in battery technology, Toyota could soon become a dominant force in the electric vehicle industry. A major advancement in solid-state battery technology has been revealed by Toyota, promising to significantly reshape the electric vehicle landscape. This new generation of batteries is positioned to outperform the widely used lithium-ion versions by offering quicker charging times, extended range, and improved safety features. Toyota has built its brand on trust and durability. If buyers believe the new EVs are just as dependable as their hybrids and fuel-powered models, demand could grow rapidly. Of course, bringing this technology to market at scale won't be without its challenges. Mass production of solid-state batteries is still a complex task, and Toyota will need to fine-tune the process to ensure long-term stability and cost efficiency. Still, this innovation signals a major shift in the auto industry. If Toyota succeeds, it could usher in a new era of electric driving, one that's faster, safer, and more accessible. Rather than playing catch-up, Toyota may soon find itself leading the pack. Battery technology is evolving at a fast pace with entities like SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) deepening their market penetration to serve the EV industry, solar power and energy storage segments. The coming years promise to bring superior products that are cost-effectively priced.

SolarBank Corporation (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy by offering end-to-end services that include project origination, financing structuring, engineering, procurement, construction, and long-term operations and maintenance. SolarBank focuses on delivering innovative energy solutions through solar photovoltaic systems, battery energy storage systems (BESS), and electric vehicle (EV) charging infrastructure.

With a vision to provide scalable and reliable clean energy solutions, SolarBank has established itself as a leader in the renewable energy market by cultivating partnerships with utilities, commercial and industrial entities, municipalities, and residential customers. Its vertically integrated business model allows for optimized efficiency, cost management, and returns across diverse markets in North America. This end-to-end approach ensures greater control over project quality, costs, and operational outcomes, strengthening its competitive position.

Driven by a mission to create a greener future, SolarBank manages a robust portfolio of projects, including more than 100 megawatts (MW) of developed capacity and a pipeline exceeding one gigawatt (GW). The company’s commitment to sustainability and innovation makes it a recognized player in the renewable energy sector.

SolarBank has offices in Toronto, Ontario and New York.

Projects

SolarBank boasts an impressive and diverse portfolio of renewable energy initiatives that underline its leadership in the clean energy space. In the U.S., the company has over 250 MW of solar projects under development, principally in New York, focusing on community solar farms and commercial and industrial installations. Notably, SolarBank is developing several community solar projects in upstate New York, which will deliver clean energy to local residents and small businesses. Community solar projects, which are a cornerstone of SolarBank’s portfolio, provide scalable solutions for renters, homeowners, and small businesses to access affordable renewable energy, driving localized energy independence and economic savings.

In Canada, SolarBank has been a significant participant in Ontario’s Feed-in-Tariff program, where it has secured contracts for close to 200 MW of capacity. Its current management includes 70 solar power projects, totaling 28.8 MW of operational solar assets. The company’s expertise extends to the development and ownership of battery energy storage systems and EV charging stations, further diversifying its portfolio.

The company’s vertically integrated approach spans the entire project lifecycle, from initial site acquisition and grid interconnection to long-term operation and maintenance services. This ensures seamless execution and high-quality outcomes, providing value to stakeholders and supporting the transition to a clean energy future.

Market Opportunity

SolarBank operates within a growing renewable energy market driven by global demand for sustainable power solutions. In North America, favorable policies such as the Inflation Reduction Act in the United States and Canada’s investments in green technologies provide a robust foundation for renewable energy adoption. Solar PV installations and battery energy storage systems are at the forefront of this expansion, addressing energy reliability and grid stability while reducing carbon emissions.

The North American solar PV market was valued at $25.02 billion in 2019 and is projected to reach $120.74 billion by 2027, growing at a compound annual growth rate (CAGR) of 21.7% from 2020 to 2027. Likewise, the global BESS market is expected to expand from $7.8 billion in 2024 to $25.6 billion by 2029, at a CAGR of 26.9%, as reported by MarketsandMarkets. These trends are driven by the increasing integration of renewable energy sources, the need for grid resilience, and declining technology costs.

SolarBank’s operations have it well-positioned to capitalize on these opportunities. With a development pipeline exceeding one gigawatt (GW), the company is focused on meeting growing demand in community and commercial solar sectors. Decentralized energy solutions, such as virtual net metering and behind-the-meter systems, further enhance SolarBank’s market potential by addressing the critical need for flexible, cost-effective, and sustainable energy infrastructure. By leveraging its vertically integrated model and diversified portfolio, SolarBank stands as a key player in driving the renewable energy transition.

Leadership Team

Dr. Richard Lu, MD, MSc., MHSc., MBA, serves as President and CEO of SolarBank, bringing over 25 years of global energy experience. His leadership has been instrumental in advancing the company’s strategic initiatives across North America, Europe, and Asia, with a focus on renewable energy development and operational excellence.

Sam Sun, MBA, is the Chief Financial Officer of SolarBank. A Chartered Professional Accountant with more than 15 years of expertise in corporate finance, Mr. Sun has overseen financial strategies and internal controls across the cleantech, manufacturing, and mining sectors in Canada, the U.S., and China.

Andrew van Doorn, PE, serves as Chief Operating Officer, with nearly three decades of experience in engineering and construction. Mr. van Doorn has successfully led projects totaling over 200 MW of solar capacity and is a former Chairman of the Canadian Solar Industries Association.

Tracy Zheng, MBA, Chief Development Officer, has over 25 years of experience in brand marketing, business development, and solar project operations. She has spearheaded sales initiatives, conducted feasibility studies, and negotiated key partnerships that drive SolarBank’s growth.

Matt Wayrynen, Executive Chairman and Director, has a background in resource company management, venture capital, and mergers and acquisitions. Under his leadership, Solar Flow-Through Funds, where Mr. Wayrynen acted as CEO, was acquired by SolarBank, enhancing its asset portfolio and growth prospects.


Forward Looking Statements

This report contains forward-looking statements and forward-looking information ‎within the meaning of Canadian securities legislation (collectively, “forward-looking ‎statements”) that relate to the Company’s current expectations and views of future events. ‎Any statements that express, or involve discussions as to, expectations, beliefs, plans, ‎objectives, assumptions or future events or performance (often, but not always, through the ‎use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will ‎continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, ‎‎”projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be ‎forward-looking statements and may involve estimates, assumptions and uncertainties ‎which could cause actual results or outcomes to differ materially from those expressed in ‎such forward-looking statements. In particular and without limitation, this report ‎contains forward-looking statements pertaining to the Company’s expectations regarding its industry trends and overall market growth of the data center market; the Company’s expansion into the data center market, including its pursuit of opportunities as a developer, owner, and strategic partner in data center infrastructure; supporting the demand for high-performance, sustainable energy solutions within the sector; details of the company’s business plan including development of solar power projects, battery storage projects and EV charging projects; the completion of any contracts for, or construction of, any data center, solar power, battery storage or EV projects; the receipt of interconnection approval, permits and financing to be able to construct projects; the receipt of incentives for projects; and the size of the Company’s development pipeline. No assurance ‎can be given that these expectations will prove to be correct and such forward-looking ‎statements included in this report should not be unduly relied upon. These ‎statements speak only as of the date of this report.‎

Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. In making the forward looking statements included in this report, the Company has made various material assumptions, including but not limited to: obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the availability of financing on reasonable terms; the Company’s ability to attract and retain skilled staff; market competition; the products and services offered by the Company’s competitors; that the Company’s current good relationships with its service providers and other third parties will be maintained; and government subsidies and funding for renewable energy will continue as currently contemplated. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements.

Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Forward-‎Looking Statements” and “Risk ‎Factors” in the Company’s most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions; the execution of the Company’s growth strategy depends upon the continued availability of third-party financing arrangements; the Company’s future success depends partly on its ability to expand the pipeline of its energy business in several key markets; governments may revise, reduce or eliminate incentives and policy support schemes for solar and battery storage power; general global economic conditions may have an adverse impact on our operating performance and results of operations; the Company’s project development and construction activities may not be successful; developing and operating solar projects exposes the Company to various risks; the Company faces a number of risks involving Power Purchase Agreements (“PPAs”) and project-level financing arrangements; any changes to the laws, regulations and policies that the Company is subject to may present technical, regulatory and economic barriers to the purchase and use of solar power; the markets in which the Company competes are highly competitive and evolving quickly; an anti-circumvention investigation could adversely affect the Company by potentially raising the prices of key supplies for the construction of solar power projects; foreign exchange rate fluctuations; a change in the Company’s effective tax rate can have a significant adverse impact on its business; seasonal variations in demand linked to construction cycles and weather conditions may influence the Company’s results of operations; the Company may be unable to generate sufficient cash flows or have access to external financing; the Company may incur substantial additional indebtedness in the future; the Company is subject to risks from supply chain issues; risks related to inflation; unexpected warranty expenses that may not be adequately covered by the Company’s insurance policies; if the Company is unable to attract and retain key personnel, it may not be able to compete effectively in the renewable energy market; there are a limited number of purchasers of utility-scale quantities of electricity; compliance with environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems and may be subject to damaging cyberattacks; the Company may become subject to litigation; there is no guarantee on how the Company will use its available funds; the Company will continue to sell securities for cash to fund operations, capital expansion, mergers and acquisitions that will dilute the current shareholders; and future dilution as a result of financings.

The Company undertakes no obligation to update or revise any ‎forward-looking statements, whether as a result of new information, future events or ‎otherwise, except as may be required by law. New factors emerge from time to time, and it ‎is not possible for the Company to predict all of them, or assess the impact of each such ‎factor or the extent to which any factor, or combination of factors, may cause results to ‎differ materially from those contained in any forward-looking statement. Any forward-‎looking statements contained in this report are expressly qualified in their entirety by ‎this cautionary statement.‎

SolarBank Corp. (NASDAQ: SUUN), closed Wednesday's trading session at $1.44, off by 5.8824%, on 27,315 volume. The average volume for the last 3 months is 293,372 and the stock's 52-week low/high is $1.23/$6.65.

Recent News

FAVO Capital Inc. (OTC: FAVO)

The QualityStocks Daily Newsletter would like to spotlight FAVO Capital Inc. (NASDAQ: FAVO).

FAVO Capital (OTC: FAVO) is a rapidly growing private credit company dedicated to providing fast, efficient, and personalized funding solutions for small and medium-sized businesses ("SMBs"). "FAVO Capital has more than $138 million in total funding supporting more than 10,000 businesses. The company leverages artificial intelligence (‘AI')-powered analytics to provide faster, smarter funding decisions," reads a recent article. "Publicly listed and regulated, FAVO Capital is committed to transparency and investor confidence. The company has expanded its market reach, currently operating in 45 states and the Dominican Republic. FAVO's fast, flexible financing can result in funding delivered within hours, as it executes on its strategic expertise combined with cutting-edge fintech solutions."

To view the full article, visit https://ibn.fm/fYIgh

FAVO Capital Inc. (OTC: FAVO) is redefining the private credit and alternative lending industry through a strategic redevelopment of its operations and offerings. With a focus on leveraging financial technology and a client-centric approach, FAVO Capital empowers small to medium-sized businesses with fast, flexible, and reliable access to capital, bridging the gap left by traditional financial institutions.

Empowering Businesses, Redefining Private Credit

As part of its strategy to uplist to Nasdaq, FAVO Capital is enhancing its technology platform, operational scalability, and market positioning to meet higher regulatory standards and attract institutional investors. Headquartered in Fort Lauderdale, Florida, FAVO employs over 120 professionals across five global offices, delivering sustainable growth and value for clients and shareholders alike.

Products and Services

  • Proprietary Lending Platform and Mobile App (In Development): FAVO Capital is in the early stages of developing an advanced digital platform designed to enhance client engagement and streamline funding processes. This platform will eventually allow businesses to apply for funding products, track progress, and manage repayment efficiencies. A complementary mobile app is also being planned to provide real-time insights and tailored recommendations, laying the groundwork for an improved borrower experience.
  • Fintech-Driven Lending Solutions: FAVO Capital is exploring proprietary and third-party technology tools, including advanced analytics and algorithms, to enhance decision-making speed and reliability in the lending process.
  • Flexible Financing Options: FAVO specializes in structuring customized capital solutions tailored to the diverse needs of small business owners, offering scalable and adaptable products that evolve with changing market conditions.

Market Opportunity

The private credit market is experiencing exponential growth as traditional banks reduce their focus on small business lending. According to industry reports, the global private credit market is projected to surpass $1.5 trillion by 2025, driven by increasing demand for alternative financing options.

FAVO Capital is uniquely positioned to capture market share within this booming sector by leveraging fintech innovation to meet the needs of underserved small businesses. With a focus on efficiency, speed, and client satisfaction, FAVO addresses critical gaps in the financial ecosystem while building a platform for long-term growth.

Recent Highlights

  • Fintech Innovation: Initial investments in app development and analytics lay the groundwork for future operational efficiency and improved borrower experience.
  • Operational Scale: A global footprint with over 120 employees combines the agility of a local lender with the reach of an international financial institution.
  • Proven Growth: FAVO’s technology-driven approach has enabled consistent expansion, solidifying its reputation as a trusted partner for small businesses.

Leadership Team

Vincent Napolitano is a Founder and CEO of FAVO Capital Inc. With over two decades of experience in finance and business development, Vincent has been instrumental in building FAVO Capital into a trusted partner for businesses seeking innovative financial strategies. Prior to founding FAVO Capital, Vincent spent 25 years on Wall Street, holding key positions at prominent firms and developing expertise in structuring complex financial deals. He also served as Chief Investment Officer for multiple special purpose vehicles (SPVs), acquiring private stock in pre-IPO unicorn companies such as Facebook and Twitter.

Shaun Quin is a Founding Member and President of FAVO Capital Inc., overseeing the company’s mission to deliver innovative and efficient private credit solutions to small and medium-sized businesses. With over 20 years of global experience as a partner, investor, and director, Shaun brings a strategic and customer-focused approach to his leadership. His expertise in fostering collaboration, building high-performance cultures, and empowering businesses has positioned FAVO Capital as a trusted leader in private lending.

Vaughan Korte, CFO, brings over 15 years of global financial expertise to his role with FAVO Capital Inc. His track record includes managing financial operations for Adidas across 60 countries with budgets exceeding $500 million. Vaughan’s leadership ensures FAVO Capital remains financially resilient, aligning financial strategy with organizational goals and fostering shareholder value.

Glen Steward, Chief Strategy Officer, is a seasoned entrepreneur with over 28 years of experience in the investment and trading industries. He drives FAVO Capital’s strategic initiatives, ensuring the company remains competitive and agile in a rapidly evolving market. Glen has held directorships and board memberships across Mauritius, South Africa, and the United States. His strategic acumen has been pivotal in integrating the FAVO Group of Companies into FAVO Capital Inc., fueling growth and market leadership.

Advisory Board

Bilal Adam, Accounting & Financial Counsel, is a financial expert with over 20 years of experience, including roles as CEO of Stewards Investment Capital. His insights into bespoke investment solutions, including fixed income, equity, and digital assets, support FAVO Capital’s innovative approach to private credit.

Honorable Earnest Hart, Corporate Governance Counsel, brings decades of legal and governance experience, having served as a New York Supreme Court Judge and COO at Columbia University Medical Center. His guidance ensures FAVO Capital maintains robust corporate governance standards.

Rocco Trotta, Business Leadership and Scalability Counsel, is the co-founder of LiRo-Hill and has decades of experience scaling businesses. His expertise in organizational efficiency and talent development strengthens FAVO Capital’s ability to attract excellence across all aspects of the business.

As FAVO Capital redevelops its operations and prepares for an uplisting to Nasdaq, the company is laying the foundation to redefine private credit with emerging fintech solutions and exceptional leadership. Learn more by visiting investors.favocap.com.

Investment Considerations
  • Early-Stage Technology Development: Laying the groundwork for proprietary platforms and scalable digital tools.
  • Significant Market Opportunity: The private credit market is projected to exceed $1.5 trillion by 2025, providing exponential growth potential.
  • Scalable Business Model: Automated processes and data-driven decision-making enable rapid scaling with minimal overhead.
  • Customer-Centric Approach: FAVO’s focus on small businesses and flexible financing solutions addresses critical gaps in the financial ecosystem.
  • Experienced Leadership: A forward-thinking executive team ensures strategic growth and innovation.

FAVO Capital Inc. (OTC: FAVO), closed Wednesday's trading session at $1.35, off by 2.1739%, on 1,901 volume. The average volume for the last 3 months is 100 and the stock's 52-week low/high is $0.162/$1.45.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) has entered into an engagement with Red Cloud Securities Inc. for a "best efforts" private placement of up to $10 million in units priced at $1.20 each, with an option to raise an additional $1.5 million. Each unit includes one common share and one-half of a warrant exercisable at $1.75 for 36 months. Net proceeds will fund key initiatives related to Ucore's planned Strategic Metals Complex in Louisiana, including securing feedstock and customer agreements, advancing engineering plans, and fulfilling obligations with the U.S. Department of Defense and Natural Resources Canada. The offering is set to close on or about June 19, 2025, pending necessary approvals.

To view the full press release, visit https://ibn.fm/GodME

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) s a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America. Originally founded in 2006 as a mineral exploration company, Ucore has since evolved into a processing technology innovator focused on commercializing its proprietary RapidSX™ platform under a $18.4 million contract from the U.S. Department of Defense, with additional support from Natural Resources Canada. The company’s flagship deployment is the Louisiana Strategic Metals Complex (“SMC”), with additional SMCs planned to follow.

Ucore’s mission is to help reestablish a domestic REE supply chain by offering competitive, modular processing solutions that reduce dependence on China. Supported by government funding, private capital, and engineering partnerships, Ucore aims to meet growing demand for rare earth oxides in electric vehicles, defense systems, and advanced energy technologies.

The company is headquartered in Halifax, Nova Scotia.

 

Projects & Technology

RapidSX™ Separation Technology

RapidSX™ is Ucore’s proprietary rare earth separation platform, delivering three times faster processing than traditional solvent extraction (SX) methods. Its current demonstration program in Kingston, Ontario, is being conducted under contract with the U.S. Department of Defense to prove commercial readiness for processing both heavy and light REEs. The project is also supported by Natural Resources Canada.

RapidSX™ employs a column-based design that eliminates the need for powered mixer-settlers, enabling a smaller facility footprint, quicker commissioning, and lower CAPEX and OPEX. The platform is adaptable to light and heavy REE feedstocks and is structured for modular scale-up.

The 52-stage RapidSX™ Commercial Demonstration Plant in Kingston, Ontario—operated in partnership with Kingston Process Metallurgy—has logged thousands of runtime hours and is currently processing rare earth feedstock further to the company’s U.S. Department of Defense contract. In January 2025, Ucore secured a $500,000 non-dilutive grant from Ontario’s Critical Minerals Innovation Fund to support the advancement of the Kingston facility and, in the words of Ontario Mines Minister George Pirie, “build a secure supply chain ready to fuel the technologies of tomorrow.”

Strategic Metals Complex – Louisiana

Ucore has selected an 80,800-square-foot brownfield site within the England Airpark in Alexandria, Louisiana, as the location for its first commercial rare earth refining facility. The Louisiana SMC is expected to scale from 2,000 tonnes per annum (TPA) of total rare earth oxides initially to 5,000 TPA, with potential to ultimately reach 7,500 TPA.

The facility benefits from Foreign Trade Zone (FTZ) status, reducing tariff burdens on imported inputs and enhancing logistics efficiency. In addition to these structural advantages, the state of Louisiana has outlined an incentive package valued at $15 million, including a $900,000 infrastructure grant and $360,000 in additional local support. The project is expected to create 100 family-wage jobs and has received strong support from federal and state officials.

To date, Ucore has secured $2.3 million in milestone payments under its $18.4 million OTA award from the U.S. Department of Defense. In early 2024, the company also secured C$2.16 million in private investment from Hondo Private Equity to support its commercialization efforts.

Bokan-Dotson Ridge REE Project – Alaska

Ucore maintains 100% ownership of the Bokan-Dotson Ridge heavy REE project in Southeast Alaska. A Preliminary Economic Assessment was completed in January 2013. The Alaska Industrial Development and Export Authority (AIDEA) has authorized $145 million in bond financing under SB99 (2014) to support future development.

While Bokan remains a long-term asset, Ucore continues to advance it at a measured pace, complementing its near-term focus on commercial rare earth refining and oxide production at the Louisiana SMC.

Market Opportunity

According to Grand View Research, the global rare earth elements market was estimated at $3.95 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. The market outlook remains strong, fueled by the growing demand for permanent magnets and catalysts in the automotive sector.

In March 2025, President Trump invoked the Defense Production Act to prioritize domestic critical mineral production, signaling a national mandate to reduce reliance on “hostile foreign powers’ mineral production.” One month later, the Chinese government enacted immediate export restrictions on seven key rare earth elements, including dysprosium and terbium, further intensifying pressure on Western nations to develop secure and independent supply chains. This underscores the strategic value of Ucore’s domestic separation infrastructure.

Leadership Team

Pat Ryan, P.Eng., Chairman and CEO, is the founder of Neocon International, a leading automotive OEM supplier. He brings over 25 years of experience in global supply chain innovation and has led Ucore since 2014 in its strategic pivot toward rare earth processing.

Peter Manuel, Vice President, CFO & Corporate Secretary, has served as Ucore’s financial lead for 14 years. Trained as a Chartered Accountant, with extensive experience across Canada, England, and Ireland, Mr. Manuel has advised public and private entities on strategic planning, treasury, and assurance.

Michael Schrider, MEng, P.E., Vice President & COO, is a multidisciplinary engineer with over 30 years of experience. He founded and operated engineering firms SAi and ABD and has overseen all phases of Ucore’s technical development since 2016.

Geoff Atkins, Vice President of Business Development, has 30 years of mining experience and was instrumental in advancing both Lynas’ Mt. Weld and Vital Metals’ Nechalacho REE operations. He brings deep operational knowledge and leads feedstock strategy at Ucore.

Investment Considerations
  • The company is closely aligned with national policy, receiving funding from both the U.S. Department of Defense ($18.4 million) and Natural Resources Canada (C$4.3 million).
  • Ucore’s RapidSX™ platform promises to deliver faster REE separation than traditional SX and is being commercialized at scale.
  • The Louisiana SMC aims to ramp to 7,500 TPA rare earth oxide production and benefits from FTZ status, DoD funding, and private equity backing.
  • Ucore’s 100%-owned Bokan-Dotson Ridge project remains a potentially valuable strategic heavy REE resource supported by a $145M AIDEA bond.
  • As China imposes REE export restrictions and the U.S. escalates domestic production policy, Ucore is positioned as a secure Western alternative.

Ucore Rare Metals Inc. (OTCQX: UURAF), closed Wednesday's trading session at $0.845, off by 17.6413%, on 611,894 volume. The average volume for the last 3 months is 147,240 and the stock's 52-week low/high is $0.33/$1.64.

Recent News

GEMXX Corp. (OTC: GEMZ)

The QualityStocks Daily Newsletter would like to spotlight GEMXX Corp. (OTC: GEMZ) .

When Trump took office back in January, he vowed to support renewed production by the oil and gas industry. His executive orders during the first days of his administration sought to encourage additional exploration for oil and gas within the country while also stifling renewable energy. However, the events unfolding since those initial days in office are having the effect of alienating the very sector he promised to support. When the president announced his "Liberation Day" tariffs, the stocks of oil drillers took a major hit and approximately $280 billion in stock value was wiped off their books during the month of April. Major entities like Chevron and Exxon Mobil lost 18% and 11% of the value of their stocks, respectively. While a pause to allow for negotiations to happen isn't in itself a bad thing, it has a negative impact of keeping industry players on edge because they don't know how the talks will conclude. Additionally, practical questions arise, such as how effectively and quickly the U.S. can conduct talks with more than 100 countries simultaneously. There is an air of gloom regarding the prospects of the tariff situation being resolved expeditiously, let alone favorably. The unpredictable nature of Trump regarding trade policy has industry actors worried, and this state of affairs isn't conducive to capital investment and production increases. Even companies like GEMXX Corp. (OTC: GEMZ) with oil and gas operations in Latin America are most likely also feeling the impacts of Trump's oscillating and erratic policy announcements because the trade war he started shook global supply chains.

GEMXX Corp. (OTC: GEMZ) is a mine-to-market enterprise specializing in gold, gemstone, and jewelry production. With ownership of mining resources, production facilities, and operational assets, the company maintains control over every aspect of its production process, from gold mining and gemstone extraction to jewelry manufacturing and global distribution.

As a prominent player in the industry, GEMXX stands out as a leading producer of high-quality finished Ammolite jewelry. Notably, it holds the distinction of being the sole public company engaged in Ammolite mining worldwide. In addition to its Ammolite operations, the company is actively involved in gold mining and prides itself on its ability to design and manufacture exquisite jewelry pieces and exceptionally rare, natural fossil decor items for clientele around the globe.

One of GEMXX’s key advantages lies in mining its own gold reserves to be utilized in its jewelry production. This strategic approach provides the company with a cost-saving edge over other producers in the market.

Ammolite is similar to black opal and is a biogenic gem like amber and pearl. It is derived from the fossilized shells of ammonites, a group of extinct marine nautiluses.

GEMXX’s world class gemstone cutters and jewelry designers are continuously leading the Ammolite industry. Its team believes in the company’s philosophy, vision and goals, and works every day to continue to drive the Ammolite industry to the forefront of the gem world.

The company has offices in Las Vegas and Hong Kong.

Projects and Operations

GEMXX has formulated an ambitious growth plan that, while challenging, is deemed attainable. The company’s strategy revolves around bolstering its market share through several key initiatives. Firstly, GEMXX aims to strengthen its position in current markets by nurturing and expanding existing relationships with customers and partners.

Secondly, the company plans to venture into untapped markets strategically. By identifying and targeting new areas, GEMXX seeks to establish a presence in regions that present promising opportunities for growth.

Additionally, GEMXX envisions growth through acquisitions. By considering and integrating key services, distribution networks and retail outlets into its fold, the company aims to consolidate its market position and capitalize on synergies for enhanced success.

To cater to the rising demand for its products, GEMXX has placed a primary focus on increasing gemstone production. The company’s southern properties, situated in Alberta, Canada, hold valuable deposits of rough Ammolite gemstone. By tapping into these resources, GEMXX is poised to meet the demand for its exquisite gemstone products and further fuel its expansion plans.

 

GEMXX possesses significant mineral assets in the form of a Mineral Work Permit covering an 800-acre area and two Ammonite Shell Mineral agreements encompassing 217 acres within the same region. The company’s management effectively operated mines in close proximity to these properties. Moreover, core sampling, along with fossil outcroppings on the riverbanks, confirms a substantial Ammolite resource present in these designated areas.

Both the Mineral Work Permit and the Ammonite Shell Mineral agreements grant GEMXX unrestricted access to all Ammolite resources within their respective demarcations. Notably, the company is not obligated to pay any royalties to third parties, thereby enabling GEMXX to fully capitalize on the potential of these valuable resources.

Furthermore, there are no stringent regulatory conditions that GEMXX must fulfill to gain or retain access to the Ammolite deposits. This freedom of access allows the company to proceed with its mining and production operations unimpeded, providing an advantageous position for future growth and success.

In March 2023, GEMXX made a significant announcement, revealing its acquisition of a 50% ownership stake in Crazy Horse Mining Inc., a Canadian gold mining company with assets situated in the province of British Columbia. As part of this deal, Crazy Horse’s assets, which encompass a 100% interest in two gold projects, called Snow Creek and Rosella Creek, spread across a substantial area exceeding 700 acres, now become part of GEMXX’s portfolio.

Under the terms of this strategic partnership, GEMXX and Crazy Horse will jointly share the expenses related to mining operations on these projects. Additionally, the two companies will share the gold produced from these ventures, leading to a collaborative and mutually beneficial arrangement.

Initial tests conducted on the property, combined with gold already recovered this season, confirm all expectations for the claims and substantiate the company’s estimated extraction target of over 100,000 ounces of easily recoverable gold. To validate and provide a more comprehensive assessment of this estimate, an S-K 1300-compliant Resource Report is scheduled to be conducted during the summer of 2023.

By acquiring this stake in Crazy Horse Mining Inc., GEMXX has positioned itself for further growth in the gold mining sector and is poised to capitalize on cost of goods savings in its jewelry business.

Market Opportunity

Leading independent market research companies such as Data Monitor and GIA estimate the worldwide market for luxury or premium lifestyle products, which include gems and jewelry, at over $90 billion annually and growing. Ammolite sales around the world have seen unprecedented growth over the past 20 years. Worldwide retail sales are now estimated to be over $100 million.

Ammolite jewelry and fossils are featured aboard cruise ships and can be found in specialty shops in almost every cruise port in North America. Asian markets have grown since feng shui master Edward Li called Ammolite the most influential stone of the new millennium, referring to it as the “Seven Color Prosperity Stone.” Home shopping channels in Japan, Australia, France, Germany, the UK, Canada and the U.S. have all featured Ammolite jewelry.

Ammolite and ammonites can also be found on many ecommerce sales platforms, including Amazon, eBay and Etsy. Ammolite is sold around the world in tourist and traditional jewelry markets. The company has established customers in home shopping channels, cruise tourism, jewelry retailers, Asian feng shui markets, Asian retail markets and ecommerce platforms.

Management Team

With over 160 years in Ammolite management, operations, and sales, GEMXX possesses an unparalleled wealth of knowledge and expertise. Its team members have extensive backgrounds in every facet of the Ammolite business, allowing the company to excel in product development, maintain rigorous quality control measures, and maximize profitability. The breadth and depth of the GEMXX team’s experience enable the company to navigate the industry with precision, ensuring that GEMXX remains at the forefront of the Ammolite market. GEMXX leverages its collective wisdom to drive innovation, deliver exceptional products, and optimize business strategies to achieve long-term success.

Jay Maull is Founder, CEO and Chairman of GEMXX. With a career spanning more than three decades, he has been deeply involved in the Ammolite industry, from mining and production to marketing. He has owned and operated the world’s largest Ammolite mine and has delivered exceptional Ammolite products to customers across all continents. He has also established the world’s largest Ammolite ecommerce platform.

Richard Clowater is President of GEMXX. He is a skilled sales and marketing professional with a focus on research, data analysis and strategic planning. He has successfully implemented initiatives to expand markets, boost profits and foster customer loyalty. He has an impressive track record of negotiating sales and contracts worth over $250 million with influential stakeholders, including key purchasing personnel, C-suite executives and government entities at all levels.

Tom Dryden is a Vice President of GEMXX and brings a wealth of experience and expertise to the production and marketing of Ammolite, spanning over 30 years. His extensive involvement in the industry has granted him unparalleled knowledge of the Bearpaw Ammonite bearing formations. As a recognized authority in the field, Mr. Dryden’s research and papers on Canadian Ammonites have garnered global recognition, being published worldwide. In his role at GEMXX, Mr. Dryden assumes the responsibility of overseeing the company’s Canadian-based production facilities. 

P. K. Chung is Business Manager Asia at GEMXX. With a track record of over 25 years in Ammolite business management, production and marketing in Asia, she is a recognized authority in the industry. Based in the Hong Kong gem district, she possesses an intricate understanding of the Asian gem and jewelry markets, including market dynamics, consumer preferences and industry trends specific to the region. Her strategic insights and deep connections enable GEMXX to thrive in this influential market.

GEMXX Corp. (OTC: GEMZ), closed Wednesday's trading session at $0.011, off by 35.2941%, on 17,808 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0023/$0.03.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.